The TMEM43 S358L mutation affects cardiac, small intestine, and metabolic homeostasis in a knock-in mouse model

This manuscript describes the findings of our investigation of cardiac, small intestine, and metabolic features of Tmem43-S358L mouse model. By investigating interorgan pathologies, we uncovered multiple mechanisms of the S358L-induced disease, and these unique mechanisms likely appear to contribute...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of physiology. Heart and circulatory physiology Vol. 324; no. 6; pp. H866 - H880
Main Authors Orgil, Buyan-Ochir, Munkhsaikhan, Undral, Pierre, Joseph F., Li, Ning, Xu, Fuyi, Alberson, Neely R., Johnson, Jason N., Wetzel, Glenn T., Boukens, Bastiaan J. D., Lu, Lu, Towbin, Jeffrey A., Purevjav, Enkhsaikhan
Format Journal Article
LanguageEnglish
Published United States American Physiological Society 01.06.2023
Subjects
Online AccessGet full text
ISSN0363-6135
1522-1539
1522-1539
DOI10.1152/ajpheart.00712.2022

Cover

Loading…
Abstract This manuscript describes the findings of our investigation of cardiac, small intestine, and metabolic features of Tmem43-S358L mouse model. By investigating interorgan pathologies, we uncovered multiple mechanisms of the S358L-induced disease, and these unique mechanisms likely appear to contribute to the disease pathogenesis. We hope our findings are important and novel and open new avenues in the hunting for additional diagnostic and therapeutic targets in subjects carrying TMEM43 mutation. The transmembrane protein 43 (TMEM43/LUMA) p.S358L mutation causes arrhythmogenic cardiomyopathy named as ARVC5, a fully penetrant disease with high risk of ventricular arrhythmias, sudden death, and heart failure. Male gender and vigorous exercise independently predicted deleterious outcome. Our systems genetics analysis revealed the importance of Tmem43 for cardiac and metabolic pathways associated with elevated lipid absorption from small intestine. This study sought to delineate gender-specific cardiac, intestinal, and metabolic phenotypes in vivo and investigate underlying pathophysiological mechanisms of S358L mutation. Serial echocardiography, surface electrocardiography (ECG), treadmill running, and body EchoMRI have been used in knock-in heterozygous (Tmem43 WT/S358L ), homozygous (Tmem43 S358L ), and wildtype (Tmem43 WT ) littermate mice. Electron microscopy, histology, immunohistochemistry, transcriptome, and protein analysis have been performed in cardiac and intestinal tissues. Systolic dysfunction was apparent in 3-mo-old Tmem43 S358L and 6-mo-old Tmem43 WT/S358L mutants. Both mutant lines displayed intolerance to acute stress at 6 mo of age, arrhythmias, fibro-fatty infiltration, and subcellular abnormalities in the myocardium. Microarray analysis found significantly differentially expressed genes between left ventricular (LV) and right ventricular (RV) myocardium. Mutants displayed diminished PPARG activities and significantly reduced TMEM43 and β-catenin expression in the heart, whereas junctional plakoglobin (JUP) translocated into nuclei of mutant cardiomyocytes. Conversely, elongated villi, fatty infiltration, and overexpression of gut epithelial proliferation markers, β-catenin and Ki-67, were evident in small intestine of mutants. We defined Tmem43 S358L-induced pathological effects on cardiac and intestinal homeostasis via distinctly disturbed WNT-β-catenin and PPARG signaling thereby contributing to ARVC5 pathophysiology. Results suggest that cardiometabolic assessment in mutation carriers may be important for predictive and personalized care. NEW & NOTEWORTHY This manuscript describes the findings of our investigation of cardiac, small intestine, and metabolic features of Tmem43-S358L mouse model. By investigating interorgan pathologies, we uncovered multiple mechanisms of the S358L-induced disease, and these unique mechanisms likely appear to contribute to the disease pathogenesis. We hope our findings are important and novel and open new avenues in the hunting for additional diagnostic and therapeutic targets in subjects carrying TMEM43 mutation.
AbstractList The transmembrane protein 43 (TMEM43/LUMA) p.S358L mutation causes arrhythmogenic cardiomyopathy named as ARVC5, a fully penetrant disease with high risk of ventricular arrhythmias, sudden death, and heart failure. Male gender and vigorous exercise independently predicted deleterious outcome. Our systems genetics analysis revealed the importance of Tmem43 for cardiac and metabolic pathways associated with elevated lipid absorption from small intestine. This study sought to delineate gender-specific cardiac, intestinal, and metabolic phenotypes in vivo and investigate underlying pathophysiological mechanisms of S358L mutation. Serial echocardiography, surface electrocardiography (ECG), treadmill running, and body EchoMRI have been used in knock-in heterozygous (Tmem43WT/S358L), homozygous (Tmem43S358L), and wildtype (Tmem43WT) littermate mice. Electron microscopy, histology, immunohistochemistry, transcriptome, and protein analysis have been performed in cardiac and intestinal tissues. Systolic dysfunction was apparent in 3-mo-old Tmem43S358L and 6-mo-old Tmem43WT/S358L mutants. Both mutant lines displayed intolerance to acute stress at 6 mo of age, arrhythmias, fibro-fatty infiltration, and subcellular abnormalities in the myocardium. Microarray analysis found significantly differentially expressed genes between left ventricular (LV) and right ventricular (RV) myocardium. Mutants displayed diminished PPARG activities and significantly reduced TMEM43 and β-catenin expression in the heart, whereas junctional plakoglobin (JUP) translocated into nuclei of mutant cardiomyocytes. Conversely, elongated villi, fatty infiltration, and overexpression of gut epithelial proliferation markers, β-catenin and Ki-67, were evident in small intestine of mutants. We defined Tmem43 S358L-induced pathological effects on cardiac and intestinal homeostasis via distinctly disturbed WNT-β-catenin and PPARG signaling thereby contributing to ARVC5 pathophysiology. Results suggest that cardiometabolic assessment in mutation carriers may be important for predictive and personalized care.NEW & NOTEWORTHY This manuscript describes the findings of our investigation of cardiac, small intestine, and metabolic features of Tmem43-S358L mouse model. By investigating interorgan pathologies, we uncovered multiple mechanisms of the S358L-induced disease, and these unique mechanisms likely appear to contribute to the disease pathogenesis. We hope our findings are important and novel and open new avenues in the hunting for additional diagnostic and therapeutic targets in subjects carrying TMEM43 mutation.The transmembrane protein 43 (TMEM43/LUMA) p.S358L mutation causes arrhythmogenic cardiomyopathy named as ARVC5, a fully penetrant disease with high risk of ventricular arrhythmias, sudden death, and heart failure. Male gender and vigorous exercise independently predicted deleterious outcome. Our systems genetics analysis revealed the importance of Tmem43 for cardiac and metabolic pathways associated with elevated lipid absorption from small intestine. This study sought to delineate gender-specific cardiac, intestinal, and metabolic phenotypes in vivo and investigate underlying pathophysiological mechanisms of S358L mutation. Serial echocardiography, surface electrocardiography (ECG), treadmill running, and body EchoMRI have been used in knock-in heterozygous (Tmem43WT/S358L), homozygous (Tmem43S358L), and wildtype (Tmem43WT) littermate mice. Electron microscopy, histology, immunohistochemistry, transcriptome, and protein analysis have been performed in cardiac and intestinal tissues. Systolic dysfunction was apparent in 3-mo-old Tmem43S358L and 6-mo-old Tmem43WT/S358L mutants. Both mutant lines displayed intolerance to acute stress at 6 mo of age, arrhythmias, fibro-fatty infiltration, and subcellular abnormalities in the myocardium. Microarray analysis found significantly differentially expressed genes between left ventricular (LV) and right ventricular (RV) myocardium. Mutants displayed diminished PPARG activities and significantly reduced TMEM43 and β-catenin expression in the heart, whereas junctional plakoglobin (JUP) translocated into nuclei of mutant cardiomyocytes. Conversely, elongated villi, fatty infiltration, and overexpression of gut epithelial proliferation markers, β-catenin and Ki-67, were evident in small intestine of mutants. We defined Tmem43 S358L-induced pathological effects on cardiac and intestinal homeostasis via distinctly disturbed WNT-β-catenin and PPARG signaling thereby contributing to ARVC5 pathophysiology. Results suggest that cardiometabolic assessment in mutation carriers may be important for predictive and personalized care.NEW & NOTEWORTHY This manuscript describes the findings of our investigation of cardiac, small intestine, and metabolic features of Tmem43-S358L mouse model. By investigating interorgan pathologies, we uncovered multiple mechanisms of the S358L-induced disease, and these unique mechanisms likely appear to contribute to the disease pathogenesis. We hope our findings are important and novel and open new avenues in the hunting for additional diagnostic and therapeutic targets in subjects carrying TMEM43 mutation.
The transmembrane protein 43 (TMEM43/LUMA) p.S358L mutation causes arrhythmogenic cardiomyopathy named as ARVC5, a fully penetrant disease with high risk of ventricular arrhythmias, sudden death, and heart failure. Male gender and vigorous exercise independently predicted deleterious outcome. Our systems genetics analysis revealed the importance of for cardiac and metabolic pathways associated with elevated lipid absorption from small intestine. This study sought to delineate gender-specific cardiac, intestinal, and metabolic phenotypes in vivo and investigate underlying pathophysiological mechanisms of S358L mutation. Serial echocardiography, surface electrocardiography (ECG), treadmill running, and body EchoMRI have been used in knock-in heterozygous (Tmem43 ), homozygous (Tmem43 ), and wildtype (Tmem43 ) littermate mice. Electron microscopy, histology, immunohistochemistry, transcriptome, and protein analysis have been performed in cardiac and intestinal tissues. Systolic dysfunction was apparent in 3-mo-old Tmem43 and 6-mo-old Tmem43 mutants. Both mutant lines displayed intolerance to acute stress at 6 mo of age, arrhythmias, fibro-fatty infiltration, and subcellular abnormalities in the myocardium. Microarray analysis found significantly differentially expressed genes between left ventricular (LV) and right ventricular (RV) myocardium. Mutants displayed diminished PPARG activities and significantly reduced TMEM43 and β-catenin expression in the heart, whereas junctional plakoglobin (JUP) translocated into nuclei of mutant cardiomyocytes. Conversely, elongated villi, fatty infiltration, and overexpression of gut epithelial proliferation markers, β-catenin and Ki-67, were evident in small intestine of mutants. We defined S358L-induced pathological effects on cardiac and intestinal homeostasis via distinctly disturbed WNT-β-catenin and PPARG signaling thereby contributing to ARVC5 pathophysiology. Results suggest that cardiometabolic assessment in mutation carriers may be important for predictive and personalized care. This manuscript describes the findings of our investigation of cardiac, small intestine, and metabolic features of Tmem43-S358L mouse model. By investigating interorgan pathologies, we uncovered multiple mechanisms of the S358L-induced disease, and these unique mechanisms likely appear to contribute to the disease pathogenesis. We hope our findings are important and novel and open new avenues in the hunting for additional diagnostic and therapeutic targets in subjects carrying TMEM43 mutation.
The transmembrane protein 43 (TMEM43/LUMA) p.S358L mutation causes arrhythmogenic cardiomyopathy named as ARVC5, a fully penetrant disease with high risk of ventricular arrhythmias, sudden death, and heart failure. Male gender and vigorous exercise independently predicted deleterious outcome. Our systems genetics analysis revealed the importance of Tmem43 for cardiac and metabolic pathways associated with elevated lipid absorption from small intestine. This study sought to delineate gender-specific cardiac, intestinal, and metabolic phenotypes in vivo and investigate underlying pathophysiological mechanisms of S358L mutation. Serial echocardiography, surface electrocardiography (ECG), treadmill running, and body EchoMRI have been used in knock-in heterozygous (Tmem43WT/S358L), homozygous (Tmem43S358L), and wildtype (Tmem43WT) littermate mice. Electron microscopy, histology, immunohistochemistry, transcriptome, and protein analysis have been performed in cardiac and intestinal tissues. Systolic dysfunction was apparent in 3-mo-old Tmem43S358L and 6-mo-old Tmem43WT/S358L mutants. Both mutant lines displayed intolerance to acute stress at 6 mo of age, arrhythmias, fibro-fatty infiltration, and subcellular abnormalities in the myocardium. Microarray analysis found significantly differentially expressed genes between left ventricular (LV) and right ventricular (RV) myocardium. Mutants displayed diminished PPARG activities and significantly reduced TMEM43 and β-catenin expression in the heart, whereas junctional plakoglobin (JUP) translocated into nuclei of mutant cardiomyocytes. Conversely, elongated villi, fatty infiltration, and overexpression of gut epithelial proliferation markers, β-catenin and Ki-67, were evident in small intestine of mutants. We defined Tmem43 S358L-induced pathological effects on cardiac and intestinal homeostasis via distinctly disturbed WNT-β-catenin and PPARG signaling thereby contributing to ARVC5 pathophysiology. Results suggest that cardiometabolic assessment in mutation carriers may be important for predictive and personalized care.
This manuscript describes the findings of our investigation of cardiac, small intestine, and metabolic features of Tmem43-S358L mouse model. By investigating interorgan pathologies, we uncovered multiple mechanisms of the S358L-induced disease, and these unique mechanisms likely appear to contribute to the disease pathogenesis. We hope our findings are important and novel and open new avenues in the hunting for additional diagnostic and therapeutic targets in subjects carrying TMEM43 mutation. The transmembrane protein 43 (TMEM43/LUMA) p.S358L mutation causes arrhythmogenic cardiomyopathy named as ARVC5, a fully penetrant disease with high risk of ventricular arrhythmias, sudden death, and heart failure. Male gender and vigorous exercise independently predicted deleterious outcome. Our systems genetics analysis revealed the importance of Tmem43 for cardiac and metabolic pathways associated with elevated lipid absorption from small intestine. This study sought to delineate gender-specific cardiac, intestinal, and metabolic phenotypes in vivo and investigate underlying pathophysiological mechanisms of S358L mutation. Serial echocardiography, surface electrocardiography (ECG), treadmill running, and body EchoMRI have been used in knock-in heterozygous (Tmem43 WT/S358L ), homozygous (Tmem43 S358L ), and wildtype (Tmem43 WT ) littermate mice. Electron microscopy, histology, immunohistochemistry, transcriptome, and protein analysis have been performed in cardiac and intestinal tissues. Systolic dysfunction was apparent in 3-mo-old Tmem43 S358L and 6-mo-old Tmem43 WT/S358L mutants. Both mutant lines displayed intolerance to acute stress at 6 mo of age, arrhythmias, fibro-fatty infiltration, and subcellular abnormalities in the myocardium. Microarray analysis found significantly differentially expressed genes between left ventricular (LV) and right ventricular (RV) myocardium. Mutants displayed diminished PPARG activities and significantly reduced TMEM43 and β-catenin expression in the heart, whereas junctional plakoglobin (JUP) translocated into nuclei of mutant cardiomyocytes. Conversely, elongated villi, fatty infiltration, and overexpression of gut epithelial proliferation markers, β-catenin and Ki-67, were evident in small intestine of mutants. We defined Tmem43 S358L-induced pathological effects on cardiac and intestinal homeostasis via distinctly disturbed WNT-β-catenin and PPARG signaling thereby contributing to ARVC5 pathophysiology. Results suggest that cardiometabolic assessment in mutation carriers may be important for predictive and personalized care. NEW & NOTEWORTHY This manuscript describes the findings of our investigation of cardiac, small intestine, and metabolic features of Tmem43-S358L mouse model. By investigating interorgan pathologies, we uncovered multiple mechanisms of the S358L-induced disease, and these unique mechanisms likely appear to contribute to the disease pathogenesis. We hope our findings are important and novel and open new avenues in the hunting for additional diagnostic and therapeutic targets in subjects carrying TMEM43 mutation.
Author Li, Ning
Lu, Lu
Towbin, Jeffrey A.
Munkhsaikhan, Undral
Purevjav, Enkhsaikhan
Pierre, Joseph F.
Wetzel, Glenn T.
Xu, Fuyi
Orgil, Buyan-Ochir
Alberson, Neely R.
Boukens, Bastiaan J. D.
Johnson, Jason N.
Author_xml – sequence: 1
  givenname: Buyan-Ochir
  orcidid: 0000-0001-7932-2237
  surname: Orgil
  fullname: Orgil, Buyan-Ochir
  organization: Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, United States, Children’s Foundation Research Institute, Le Bonheur Children’s Hospital Memphis, Memphis, Tennessee, United States
– sequence: 2
  givenname: Undral
  orcidid: 0000-0002-7241-9172
  surname: Munkhsaikhan
  fullname: Munkhsaikhan, Undral
  organization: Department of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee, United States
– sequence: 3
  givenname: Joseph F.
  orcidid: 0000-0002-4248-1290
  surname: Pierre
  fullname: Pierre, Joseph F.
  organization: Department of Nutritional Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States
– sequence: 4
  givenname: Ning
  orcidid: 0000-0002-1642-2393
  surname: Li
  fullname: Li, Ning
  organization: Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, United States, Children’s Foundation Research Institute, Le Bonheur Children’s Hospital Memphis, Memphis, Tennessee, United States, Department of Cardiology, Second Affiliated Hospital, Harbin Medical University, Harbin, People’s Republic of China
– sequence: 5
  givenname: Fuyi
  surname: Xu
  fullname: Xu, Fuyi
  organization: Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, Tennessee, United States, School of Pharmacy, Binzhou Medical University, Yantai, People’s Republic of China
– sequence: 6
  givenname: Neely R.
  surname: Alberson
  fullname: Alberson, Neely R.
  organization: Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, United States, Children’s Foundation Research Institute, Le Bonheur Children’s Hospital Memphis, Memphis, Tennessee, United States
– sequence: 7
  givenname: Jason N.
  surname: Johnson
  fullname: Johnson, Jason N.
  organization: Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, United States, Children’s Foundation Research Institute, Le Bonheur Children’s Hospital Memphis, Memphis, Tennessee, United States
– sequence: 8
  givenname: Glenn T.
  surname: Wetzel
  fullname: Wetzel, Glenn T.
  organization: Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, United States, Children’s Foundation Research Institute, Le Bonheur Children’s Hospital Memphis, Memphis, Tennessee, United States
– sequence: 9
  givenname: Bastiaan J. D.
  surname: Boukens
  fullname: Boukens, Bastiaan J. D.
  organization: Department of Medical Biology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
– sequence: 10
  givenname: Lu
  surname: Lu
  fullname: Lu, Lu
  organization: Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, Tennessee, United States
– sequence: 11
  givenname: Jeffrey A.
  surname: Towbin
  fullname: Towbin, Jeffrey A.
  organization: Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, United States, Children’s Foundation Research Institute, Le Bonheur Children’s Hospital Memphis, Memphis, Tennessee, United States, Pediatric Cardiology, St. Jude Children’s Research Hospital, Memphis, Tennessee, United States
– sequence: 12
  givenname: Enkhsaikhan
  orcidid: 0000-0001-6188-7176
  surname: Purevjav
  fullname: Purevjav, Enkhsaikhan
  organization: Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, United States, Children’s Foundation Research Institute, Le Bonheur Children’s Hospital Memphis, Memphis, Tennessee, United States
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37083466$$D View this record in MEDLINE/PubMed
BookMark eNp9kT9v2zAQxYkiQeKk-QQFCgJdOkQujxRFaSyC9A_gIEPdmThRJ5iOJLoiNeTbl6njJUOX4wH8vcO7e1fsbAoTMfYBxBpAyy-4P-wI57QWwoBcSyHlO7bKP7IArZozthKqUkUFSl-yqxj3QghtKnXBLpURtSqrasXCdkd8-3D_UCr-S-l6w8clYfJh4tj35FLkDufOo7vlccRh4H5KFJOf6Jbj1PGRErZh8I7vwkghJow-Zogjf5qCeypyO4YlUq4dDe_ZeY9DpJvX95r9_na_vftRbB6__7z7uimcMnUqsHGVk6YW1LUgQJadEW1To0ZoagF94xogA9BIiSA0tL3Oe9Y9QEm6L0lds8_HuYc5_FmyYTv66GgYcKLsxspaaKGghDKjn96g-7DMU3aXKTDGlKUUmfr4Si3tSJ09zH7E-dmeTpmB5gi4OcQ4U2-dP14yzegHC8K-xGZPsdl_sdmX2LJWvdGexv9P9Rcc-ZsZ
CitedBy_id crossref_primary_10_3390_cells13151264
crossref_primary_10_3390_ijms241612759
crossref_primary_10_1161_CIRCRESAHA_124_325848
Cites_doi 10.1253/circj.cj-14-0893
10.1016/j.ajhg.2008.01.010
10.1111/j.1399-0004.2012.01919.x
10.1096/fj.202100800R
10.1161/01.RES.0000179226.34112.6d
10.1093/eurheartj/ehx011
10.1186/s11658-022-00321-z
10.1073/pnas.2019681118
10.1038/s41419-017-0244-8
10.1016/j.hrthm.2019.05.007
10.1371/journal.pone.0058128
10.1083/jcb.201101100
10.1007/s00380-008-1079-0
10.14218/JCTH.2017.00005
10.1093/cvr/cvx205
10.1172/JCI30335
10.1242/jcs.019281
10.1016/j.hrthm.2020.02.028
10.1128/MCB.01034-07
10.1056/NEJMra1509267
10.1084/jem.193.7.827
10.1152/ajpheart.00295.2015
10.1002/ana.22338
10.1038/nature11799
10.1161/01.cir.65.2.384
10.1016/j.hrthm.2020.01.035
10.1161/CIRCULATIONAHA.119.040366
10.1186/s12944-019-1171-8
10.1038/ng1518
10.1152/physiolgenomics.00066.2021
10.1093/cvr/cvp183
10.1093/europace/euab077
10.1007/s13238-018-0563-2
10.1161/CIRCGENETICS.110.959031
10.1371/journal.pone.0109128
10.3389/fendo.2022.843721
10.1172/JCI27751
10.1161/CIRCGEN.119.002800
10.3389/fphys.2020.570421
10.1007/s00441-014-1865-1
10.1046/j.1440-1681.2002.03655.x
10.1111/j.1399-0004.2011.01623.x
ContentType Journal Article
Copyright Copyright American Physiological Society Jun 2023
Copyright_xml – notice: Copyright American Physiological Society Jun 2023
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7TS
7U7
8FD
C1K
FR3
P64
7X8
DOI 10.1152/ajpheart.00712.2022
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Physical Education Index
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Technology Research Database
Toxicology Abstracts
Chemoreception Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Physical Education Index
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Technology Research Database
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1522-1539
EndPage H880
ExternalDocumentID 37083466
10_1152_ajpheart_00712_2022
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: R01 HL087000
– fundername: NHLBI NIH HHS
  grantid: R01 HL053392
– fundername: NHLBI NIH HHS
  grantid: R01 HL128350
GroupedDBID ---
23M
2WC
39C
4.4
53G
5GY
5VS
6J9
AAFWJ
AAYXX
ABJNI
ACBEA
ACIWK
ACPRK
ADBBV
AENEX
AFRAH
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BKKCC
BKOMP
BTFSW
CITATION
E3Z
EBS
EMOBN
F5P
GX1
H13
ITBOX
KQ8
OK1
P2P
PQQKQ
RAP
RHI
RPL
RPRKH
TR2
UKR
W8F
WH7
WOQ
XSW
YSK
~02
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7TS
7U7
8FD
C1K
FR3
P64
7X8
ID FETCH-LOGICAL-c378t-a9c6c2780edb10124d70b98a5a19801f9c91e711922a1051bf56138f114e5f4e3
ISSN 0363-6135
1522-1539
IngestDate Fri Jul 11 08:44:27 EDT 2025
Mon Jun 30 16:46:16 EDT 2025
Thu Apr 03 07:01:09 EDT 2025
Thu Apr 24 23:11:08 EDT 2025
Tue Jul 01 02:28:00 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords PPARG
ARVC5
arrhythmogenic cardiomyopathy
Wnt-β-catenin
TMEM43/LUMA
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c378t-a9c6c2780edb10124d70b98a5a19801f9c91e711922a1051bf56138f114e5f4e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-7241-9172
0000-0001-6188-7176
0000-0001-7932-2237
0000-0002-4248-1290
0000-0002-1642-2393
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/10190833
PMID 37083466
PQID 2817774420
PQPubID 48261
ParticipantIDs proquest_miscellaneous_2805031414
proquest_journals_2817774420
pubmed_primary_37083466
crossref_citationtrail_10_1152_ajpheart_00712_2022
crossref_primary_10_1152_ajpheart_00712_2022
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-06-01
20230601
PublicationDateYYYYMMDD 2023-06-01
PublicationDate_xml – month: 06
  year: 2023
  text: 2023-06-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Bethesda
PublicationTitle American journal of physiology. Heart and circulatory physiology
PublicationTitleAlternate Am J Physiol Heart Circ Physiol
PublicationYear 2023
Publisher American Physiological Society
Publisher_xml – name: American Physiological Society
References B20
B42
B21
B22
B23
B24
B25
B26
B27
B28
B29
B30
B31
B10
B32
B11
B33
B12
B34
B13
B35
B14
B36
B15
B37
B16
B38
B17
B39
B18
B19
B1
B2
B3
B4
B5
B6
B7
B8
B9
B40
B41
References_xml – ident: B1
  doi: 10.1253/circj.cj-14-0893
– ident: B9
  doi: 10.1016/j.ajhg.2008.01.010
– ident: B10
  doi: 10.1111/j.1399-0004.2012.01919.x
– ident: B15
  doi: 10.1096/fj.202100800R
– ident: B33
  doi: 10.1161/01.RES.0000179226.34112.6d
– ident: B42
  doi: 10.1093/eurheartj/ehx011
– ident: B24
  doi: 10.1186/s11658-022-00321-z
– ident: B23
  doi: 10.1073/pnas.2019681118
– ident: B29
  doi: 10.1038/s41419-017-0244-8
– ident: B3
  doi: 10.1016/j.hrthm.2019.05.007
– ident: B40
  doi: 10.1371/journal.pone.0058128
– ident: B4
  doi: 10.1083/jcb.201101100
– ident: B19
  doi: 10.1007/s00380-008-1079-0
– ident: B39
  doi: 10.14218/JCTH.2017.00005
– ident: B14
  doi: 10.1093/cvr/cvx205
– ident: B34
  doi: 10.1172/JCI30335
– ident: B7
  doi: 10.1242/jcs.019281
– ident: B27
  doi: 10.1016/j.hrthm.2020.02.028
– ident: B30
  doi: 10.1128/MCB.01034-07
– ident: B5
  doi: 10.1056/NEJMra1509267
– ident: B38
  doi: 10.1084/jem.193.7.827
– ident: B17
  doi: 10.1152/ajpheart.00295.2015
– ident: B25
  doi: 10.1002/ana.22338
– ident: B31
  doi: 10.1038/nature11799
– ident: B2
  doi: 10.1161/01.cir.65.2.384
– ident: B26
  doi: 10.1016/j.hrthm.2020.01.035
– ident: B13
  doi: 10.1161/CIRCULATIONAHA.119.040366
– ident: B41
  doi: 10.1186/s12944-019-1171-8
– ident: B18
  doi: 10.1038/ng1518
– ident: B16
  doi: 10.1152/physiolgenomics.00066.2021
– ident: B32
  doi: 10.1093/cvr/cvp183
– ident: B36
  doi: 10.1093/europace/euab077
– ident: B12
  doi: 10.1007/s13238-018-0563-2
– ident: B28
  doi: 10.1161/CIRCGENETICS.110.959031
– ident: B11
  doi: 10.1371/journal.pone.0109128
– ident: B22
  doi: 10.3389/fendo.2022.843721
– ident: B21
  doi: 10.1172/JCI27751
– ident: B6
  doi: 10.1161/CIRCGEN.119.002800
– ident: B37
  doi: 10.3389/fphys.2020.570421
– ident: B8
  doi: 10.1007/s00441-014-1865-1
– ident: B35
  doi: 10.1046/j.1440-1681.2002.03655.x
– ident: B20
  doi: 10.1111/j.1399-0004.2011.01623.x
SSID ssj0005763
Score 2.452662
Snippet This manuscript describes the findings of our investigation of cardiac, small intestine, and metabolic features of Tmem43-S358L mouse model. By investigating...
The transmembrane protein 43 (TMEM43/LUMA) p.S358L mutation causes arrhythmogenic cardiomyopathy named as ARVC5, a fully penetrant disease with high risk of...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage H866
SubjectTerms Abnormalities
Animals
Arrhythmias, Cardiac - metabolism
Arrhythmogenic Right Ventricular Dysplasia - diagnosis
Arrhythmogenic Right Ventricular Dysplasia - genetics
beta Catenin - metabolism
Cardiac arrhythmia
Cardiomyocytes
Cardiomyopathy
Catenin
Congestive heart failure
Echocardiography
EKG
Electrocardiography
Electron microscopy
Gender
Genetics
Health risks
Histology
Homeostasis
Immunohistochemistry
In vivo methods and tests
Infiltration
Intestine
Intestine, Small
Intolerance
Lipids
Male
Metabolic pathways
Metabolism
Mice
Mutants
Mutation
Myocardium
Myocytes, Cardiac - metabolism
Pathological effects
Peroxisome proliferator-activated receptors
Phenotypes
PPAR gamma - metabolism
Proteins
Small intestine
Transcriptomes
Ventricle
Wnt protein
β-Catenin
Title The TMEM43 S358L mutation affects cardiac, small intestine, and metabolic homeostasis in a knock-in mouse model
URI https://www.ncbi.nlm.nih.gov/pubmed/37083466
https://www.proquest.com/docview/2817774420
https://www.proquest.com/docview/2805031414
Volume 324
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FIiEuCFoegYIWCXFJXGJ7_ToWlCqCpC0ikXKz1us1MSFO5TiH8n_4n8zsru1UBFS4WI6zfsjzeXZmduYbQt5EWTKQQSQsmCo9i0WMWZGLmTmCZTLlWcIExjsm5_5oxj7OvXmn83Mna2lbJSfix966kv-RKhwDuWKV7D9ItrkoHIB9kC9sQcKwvbWMp5PhhLm9L64XjnurrUke5CZNQygAqC7mmxWuQiM9BHzVOo6JQfOVrAAHiup6vZJrMBaRoiSHS_SWBShLC3YxPCB105xdY7ZZ7dmhn1CREhWqP8ESp1InsIu8xHxXtaDfjmgCvOVXHYl-v73mhXUhFnnZAqFYLjY8Xy50pHZWpCVvskIuYVIvZbuS0eYpj3ONczMxm7iG47b5V7UqBjcZ9LFWqHLPMaO_XV2EbYC6q41Hoe7o8vs04SHtLP92hV3DK6RPt7EoT1dI3yTlPr-Iz2bjcTwdzqd3yF0HvBHsEPLpc0tKDy6bquOoH86QW8Hvd3tucdMA-oNXo6yb6UPywLgl9FRj7BHpyOKQHJ0WILLVNX1LLxuhHZJ7E5OPcUTWgECqEUgVAmmNQGoQSA0C-1Thjzb461MABm3QR3fQB4MopzX6qEIfVeh7TGZnw-mHkWVaeFjCDcLK4pHwhROEA5kmyCTH0mCQRCH3uB2BbZRFIrJlYIOb4XCw9O0kQ4c2zMBLl17GpPuEHBTrQj4j1JaenyZ-COdwZvOUMy8D25Z7DjjtzGVd4tTvNRaG3x7brHyPlZ_rOXEtjFgJI0ZhdEm_OelK07v8ffhxLbDYfFqb2AntAJwo5gy65HXzN2hpXHrjhYSXBGOQd8lmNjzmUy3o5n5uAG4Q8_3ntzj7BbnffivH5KAqt_IlWMVV8kph8hfen7iz
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+TMEM43+S358L+mutation+affects+cardiac%2C+small+intestine%2C+and+metabolic+homeostasis+in+a+knock-in+mouse+model&rft.jtitle=American+journal+of+physiology.+Heart+and+circulatory+physiology&rft.au=Orgil%2C+Buyan-Ochir&rft.au=Munkhsaikhan%2C+Undral&rft.au=Pierre%2C+Joseph+F&rft.au=Li%2C+Ning&rft.date=2023-06-01&rft.issn=1522-1539&rft.eissn=1522-1539&rft.volume=324&rft.issue=6&rft.spage=H866&rft_id=info:doi/10.1152%2Fajpheart.00712.2022&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0363-6135&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0363-6135&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0363-6135&client=summon